This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bellco S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Alberto Petrucci: Innovator in Peritoneal Dialysis Systems
Introduction
Alberto Petrucci is a notable inventor based in L'Aquila, Italy. He has made significant contributions to the field of medical technology, particularly in the development of peritoneal dialysis systems. His innovative approach has the potential to improve the quality of life for patients requiring dialysis treatment.
Latest Patents
Alberto Petrucci holds a patent for a peritoneal dialysis system and cassettes therefor. This system includes a preparator and a cycler that delivers purified water into containers with different powders to create a concentrate. The concentrate is then mixed to form a peritoneal dialysis fluid (PDF), which is delivered to the patient while waste fluid is removed via a drain outlet. The system employs a volumetric approach to control hydraulic fluid paths, optimizing the flow of purified water to create the correct concentrates and subsequent PDF for cycling.
Career Highlights
Petrucci's career is marked by his dedication to advancing medical technology. His work at Bellco S.r.l. has positioned him as a key player in the development of innovative dialysis solutions. His patent reflects his commitment to enhancing patient care through technology.
Collaborations
Alberto Petrucci has collaborated with notable colleagues, including Antonio Giuseppe Marra and Salvatore Orlandini. These partnerships have contributed to the successful development and implementation of his innovative dialysis systems.
Conclusion
Alberto Petrucci's contributions to the field of peritoneal dialysis exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements that can significantly benefit patients in need of dialysis treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile